Biocept Stock News

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed w

Citizens Advice Plymouth seeing stark rise in calls to phone lines and webchats over coronavirus employment issues

What if, despite our efforts, the novel coronavirus stubbornly continues to spread in Australia at a low but appreciable rate. Should we continue to impose economically and socially stifling lockdowns

Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed w

It is universally accepted that tax breaks on investments nudge people to save more. The new tax regime has taken away the incentive to save. The deductions ensure financial wellbeing of taxpayers. Do

Biocept, Inc. (NASDAQ: BIOC) ("Biocept" or the "Company"), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the out

It doesn’t have regulatory authority, so it can’t do much, but the hundreds of registrars it authorizes can and should.

Midway through trading Monday, the Dow traded down 2.25% to 23185.53 while the NASDAQ fell 0.89% to 8,081.03. The S&P also fell, dropping 1.95% to 2,735.29. The U.S. is the...

Following the market opening Monday, the Dow traded down 1.35% to 23,399.06 while the NASDAQ fell 0.42% to 8,119.59. The S&P also fell, dropping 1.24% to 2,755.34. The U.S. is...

As the COVID-19 pandemic continues to ravage the globe, having claimed over 115,000 lives, health care companies have are pursuing diagnostics tests, potential vaccines and...

Gainers • Biocept, Inc. (NASDAQ:BIOC) stock moved upwards by 55.72% to $0.56 during Monday's pre-market session. • BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stock...